Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Beta1-Selective Blockade for Prevention of Postmenopausal Bone Loss: A Phase 2, Multi-Center, Double-Blinded, Randomized Placebo-Controlled Trial

NCT04905277 is registered in ClinicalTrials.gov with Sundeep Khosla, M.D. as lead sponsor.

NCT NCT04905277
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04905277 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Beta1-Selective Blockade for Prevention of Postmenopausal Bone Loss: A Phase 2, Multi-Center, Double-Blinded, Randomized Placebo-Controlled Trial
Lead sponsor
Sundeep Khosla, M.D.
Phase
Phase 2
Overall status
Completed
Start date
July 27, 2021
Completion date
February 2, 2026
Enrollment
420 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

healthy